$NDSN — AVOID 📊 | 6 MONTHS THESIS

$NDSN — AVOID 📊 | 6 MONTHS THESIS 🧭 Conviction: HIGH Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical compone 🎯 FQ2 FY2026 (ends Apr) | reported May 20 | Rev $741M | EPS $2.09 vs $2.52 🔴 | Margin 26.6% 💡 Consensus likely expects a rebound, but the magnitude of the miss and absence of guidance suggest persistent weakness. The market is pricing in recovery that may not materialize, while the stock's high multiple leaves it vulnerable to de-rating toward sector norms. 🏢 Business Quality: 4/10 📊 Valuation: rich — Trailing P/E 36.1x vs. sector median 21.0x; annualized EV/EBITDA ~18x vs. 🔮 Catalyst: FQ3 FY2026 earnings report ⚖️ Avoid: After a 17% EPS miss, NDSN trades at 36x earnings vs sector 21x, with no catalyst for re-rating; downside risk to $176. 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/NDSN0628

🧭 Conviction: HIGH